Recently, a phase three clinical study showed that RTA 402 can increase the estimated glomerular filtration rate (eGFR) and defend against oxidative stress in patients with chronic kidney disease (CKD) via activation of the Nrf2 signaling pathway [23,24]. The gene discussed is NFE2L2; the disease is chronic kidney disease.